Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regenxbio Inc. (RGNX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regenxbio Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1590877.
Total stock buying since 2015: $3,850,000.
Total stock sales since 2015: $96,318,700.
Total stock option exercises since 2015: $13,594,252.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 20,602 | $163,044 | 51,354 | $193,090 |
| 2024 | 0 | $0 | 198,726 | $3,223,285 | 245,335 | $1,199,020 |
| 2023 | 0 | $0 | 48,138 | $955,385 | 80,000 | $133,475 |
| 2022 | 0 | $0 | 28,878 | $967,578 | 29,900 | $25,415 |
| 2021 | 0 | $0 | 303,884 | $12,811,279 | 120,998 | $1,097,833 |
| 2020 | 0 | $0 | 283,502 | $13,127,335 | 167,311 | $1,534,207 |
| 2019 | 0 | $0 | 248,238 | $12,137,989 | 369,132 | $2,249,954 |
| 2018 | 0 | $0 | 683,586 | $39,224,436 | 861,584 | $5,746,581 |
| 2017 | 0 | $0 | 438,479 | $11,375,850 | 332,530 | $1,308,427 |
| 2016 | 0 | $0 | 206,752 | $2,332,519 | 125,000 | $106,250 |
| 2015 | 175,000 | $3,850,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-18 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,000 | 53.59 | 267,965 |
| 2019-06-18 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 12.10 | 60,500 |
| 2019-05-28 | Simpson Curran (SVP, Product Development & CTO) | Sale | 18,000 | 50.00 | 900,000 |
| 2019-05-28 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 18,000 | 22.00 | 396,000 |
| 2019-05-20 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 43.13 | 646,950 |
| 2019-05-20 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
| 2019-04-22 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 51.21 | 768,150 |
| 2019-04-22 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
| 2019-04-18 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,000 | 54.09 | 270,475 |
| 2019-04-18 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 15.80 | 79,000 |
| 2019-04-15 | Danos Olivier (Chief Scientific Officer) | Sale | 2,000 | 52.66 | 105,320 |
| 2019-04-15 | Danos Olivier (Chief Scientific Officer) | Option Ex | 2,000 | 20.35 | 40,700 |
| 2019-03-21 | Vasista Vittal (Chief Financial Officer) | Sale | 10,000 | 60.98 | 609,750 |
| 2019-03-19 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 58.48 | 877,125 |
| 2019-03-19 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
| 2019-03-12 | Danos Olivier (Chief Scientific Officer) | Option Ex | 5,000 | 20.35 | 101,750 |
| 2019-03-05 | Vasista Vittal (Chief Financial Officer) | Sale | 3,068 | 60.01 | 184,110 |
| 2019-02-25 | Simpson Curran (SVP, Product Development & CTO) | Sale | 5,300 | 54.05 | 286,465 |
| 2019-02-25 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 5,300 | 35.80 | 189,739 |
| 2019-02-15 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 47.03 | 705,495 |
| 2019-02-14 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
| 2019-02-07 | Vasista Vittal (Chief Financial Officer) | Option Ex | 120,000 | .85 | 102,000 |
| 2019-02-05 | Simpson Curran (SVP, Product Development & CTO) | Sale | 43,832 | 50.08 | 2,195,106 |
| 2019-02-05 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 43,832 | 22.60 | 990,515 |
| 2019-02-01 | Mills Kenneth T. (President and CEO) | Option Ex | 45,000 | .85 | 38,250 |
| 2019-01-15 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 44.05 | 660,750 |
| 2018-12-18 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,000 | 47.87 | 239,350 |
| 2018-12-18 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 12.10 | 60,500 |
| 2018-12-17 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 46.65 | 349,852 |
| 2018-12-17 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 46.89 | 703,305 |
| 2018-12-03 | Yoo Stephen (Chief Medical Officer) | Sale | 20,414 | 60.39 | 1,232,801 |
| 2018-12-03 | Yoo Stephen (Chief Medical Officer) | Option Ex | 20,414 | .85 | 17,351 |
| 2018-12-03 | Mills Kenneth T. (President and CEO) | Sale | 20,000 | 60.84 | 1,216,700 |
| 2018-11-30 | Danos Olivier (Chief Scientific Officer) | Option Ex | 1,500 | 20.35 | 30,525 |
| 2018-11-29 | Beshar Luke M | Sale | 12,784 | 65.00 | 830,960 |
| 2018-11-29 | Beshar Luke M | Option Ex | 12,784 | 3.76 | 48,067 |
| 2018-11-27 | Beshar Luke M | Sale | 18,786 | 65.03 | 1,221,653 |
| 2018-11-27 | Beshar Luke M | Option Ex | 18,786 | 21.36 | 401,268 |
| 2018-11-26 | Mills Kenneth T. (President and CEO) | Sale | 20,000 | 64.22 | 1,284,500 |
| 2018-11-26 | Beshar Luke M | Sale | 1,721 | 65.00 | 111,865 |
| 2018-11-26 | Beshar Luke M | Option Ex | 1,721 | 49.45 | 85,103 |
| 2018-11-21 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 61.08 | 916,155 |
| 2018-11-16 | Simpson Curran (SVP, Technical Operations) | Sale | 32,882 | 63.26 | 2,080,181 |
| 2018-11-16 | Simpson Curran (SVP, Technical Operations) | Option Ex | 32,882 | 22.00 | 723,404 |
| 2018-11-15 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 61.22 | 459,127 |
| 2018-11-07 | Christmas Patrick J. (SVP, General Counsel) | Sale | 15,000 | 72.06 | 1,080,900 |
| 2018-11-05 | Yoo Stephen (Chief Medical Officer) | Sale | 20,414 | 68.23 | 1,392,765 |
| 2018-11-05 | Yoo Stephen (Chief Medical Officer) | Option Ex | 20,414 | .85 | 17,351 |
| 2018-11-05 | Mills Kenneth T. (President and CEO) | Sale | 20,000 | 68.22 | 1,364,440 |
| 2018-11-02 | Vasista Vittal (Chief Financial Officer) | Sale | 53,741 | 70.26 | 3,775,842 |
| 2018-11-02 | Vasista Vittal (Chief Financial Officer) | Option Ex | 53,741 | 16.30 | 875,709 |
| 2018-11-01 | Vasista Vittal (Chief Financial Officer) | Sale | 19,677 | 70.04 | 1,378,177 |
| 2018-11-01 | Vasista Vittal (Chief Financial Officer) | Option Ex | 19,677 | 8.43 | 165,778 |
| 2018-10-29 | Yoo Stephen (Chief Medical Officer) | Sale | 20,414 | 62.22 | 1,270,199 |
| 2018-10-29 | Yoo Stephen (Chief Medical Officer) | Option Ex | 20,414 | .85 | 17,351 |
| 2018-10-18 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,000 | 61.96 | 309,815 |
| 2018-10-18 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 12.10 | 60,500 |
| 2018-10-16 | Yoo Stephen (Chief Medical Officer) | Sale | 10,414 | 61.18 | 637,128 |
| 2018-10-16 | Yoo Stephen (Chief Medical Officer) | Option Ex | 10,414 | .85 | 8,851 |
| 2018-10-16 | Simpson Curran (SVP, Technical Operations) | Sale | 62,309 | 60.85 | 3,791,502 |
| 2018-10-16 | Simpson Curran (SVP, Technical Operations) | Option Ex | 62,309 | 18.20 | 1,133,836 |
| 2018-10-15 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 59.26 | 444,450 |
| 2018-10-15 | Yoo Stephen (Chief Medical Officer) | Sale | 10,000 | 59.54 | 595,400 |
| 2018-10-15 | Yoo Stephen (Chief Medical Officer) | Option Ex | 10,000 | .85 | 8,500 |
| 2018-10-15 | Mills Kenneth T. (President and CEO) | Sale | 7,510 | 59.14 | 444,141 |
| 2018-10-08 | Danos Olivier (Chief Scientific Officer) | Sale | 20,000 | 64.22 | 1,284,500 |
| 2018-10-08 | Danos Olivier (Chief Scientific Officer) | Option Ex | 20,000 | 20.35 | 407,000 |
| 2018-09-17 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 75.92 | 569,400 |
| 2018-09-17 | Vasista Vittal (Chief Financial Officer) | Option Ex | 30,000 | .85 | 25,500 |
| 2018-09-17 | Mills Kenneth T. (President and CEO) | Sale | 7,510 | 75.76 | 568,950 |
| 2018-08-27 | Mills Kenneth T. (President and CEO) | Sale | 7,510 | 66.66 | 500,579 |
| 2018-08-27 | Mills Kenneth T. (President and CEO) | Option Ex | 145,000 | .85 | 123,250 |
| 2018-08-20 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,000 | 66.08 | 330,400 |
| 2018-08-20 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 12.10 | 60,500 |
| 2018-08-15 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 65.65 | 492,375 |
| 2018-07-16 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 75.96 | 569,722 |
| 2018-06-20 | Mills Kenneth T. (President and CEO) | Sale | 5,000 | 64.98 | 324,880 |
| 2018-06-19 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 1,528 | 12.10 | 18,488 |
| 2018-06-18 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,000 | 56.08 | 280,400 |
| 2018-06-18 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 12.10 | 60,500 |
| 2018-06-05 | Hayden Donald J Jr | Sale | 14,900 | 55.01 | 819,649 |
| 2018-06-05 | Hayden Donald J Jr | Option Ex | 14,900 | .85 | 12,665 |
| 2018-06-01 | Hayden Donald J Jr | Sale | 100 | 55.00 | 5,500 |
| 2018-06-01 | Hayden Donald J Jr | Option Ex | 100 | .85 | 85 |
| 2018-05-21 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 47.61 | 476,100 |
| 2018-05-15 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 49.97 | 374,752 |
| 2018-05-15 | Hayden Donald J Jr | Sale | 9,847 | 50.06 | 492,940 |
| 2018-05-15 | Hayden Donald J Jr | Option Ex | 9,847 | .85 | 8,369 |
| 2018-05-14 | Hayden Donald J Jr | Sale | 5,153 | 50.04 | 257,856 |
| 2018-05-14 | Hayden Donald J Jr | Option Ex | 5,153 | .85 | 4,380 |
| 2018-05-10 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 15,000 | 12.10 | 181,500 |
| 2018-05-09 | Christmas Patrick J. (SVP, General Counsel) | Sale | 15,000 | 43.00 | 645,000 |
| 2018-05-09 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 15,000 | 12.10 | 181,500 |
| 2018-05-09 | Hayden Donald J Jr | Sale | 15,000 | 45.00 | 675,000 |
| 2018-05-09 | Hayden Donald J Jr | Option Ex | 15,000 | .85 | 12,750 |
| 2018-04-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 39.70 | 397,050 |
| 2018-04-16 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 37.59 | 187,975 |
| 2018-04-11 | Christmas Patrick J. (SVP, General Counsel) | Sale | 10,000 | 39.00 | 390,000 |
| 2018-04-11 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 10,000 | 12.10 | 121,000 |
| 2018-04-09 | Christmas Patrick J. (SVP, General Counsel) | Sale | 10,000 | 34.00 | 340,000 |
| 2018-04-09 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 10,000 | 12.10 | 121,000 |
| 2018-03-26 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 30.00 | 150,000 |
| 2018-03-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 29.55 | 295,500 |
| 2018-03-13 | Simpson Curran (SVP, Technical Operations) | Sale | 25,000 | 33.00 | 825,000 |
| 2018-03-13 | Simpson Curran (SVP, Technical Operations) | Option Ex | 25,000 | 22.00 | 550,000 |
| 2018-03-06 | Vasista Vittal (Chief Financial Officer) | Option Ex | 60,000 | .85 | 51,000 |
| 2018-02-28 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 30.00 | 150,000 |
| 2018-02-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 26.56 | 265,600 |
| 2018-01-22 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 27.33 | 273,300 |
| 2018-01-16 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 30.16 | 150,800 |
| 2018-01-11 | Mills Kenneth T. (President and CEO) | Option Ex | 150,000 | .85 | 127,500 |
| 2018-01-05 | Vasista Vittal (Chief Financial Officer) | Option Ex | 30,000 | .85 | 25,500 |
| 2017-12-22 | Simpson Curran (SVP, Technical Operations) | Sale | 30,000 | 33.03 | 990,900 |
| 2017-12-22 | Simpson Curran (SVP, Technical Operations) | Option Ex | 30,000 | 22.00 | 660,000 |
| 2017-12-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 31.75 | 317,500 |
| 2017-12-19 | Vasista Vittal (Chief Financial Officer) | Sale | 4,994 | 30.00 | 149,820 |
| 2017-12-18 | Vasista Vittal (Chief Financial Officer) | Sale | 6 | 30.00 | 180 |
| 2017-12-07 | Simpson Curran (SVP, Technical Operations) | Sale | 21,890 | 30.04 | 657,575 |
| 2017-12-07 | Simpson Curran (SVP, Technical Operations) | Option Ex | 21,890 | 17.55 | 384,060 |
| 2017-12-04 | Simpson Curran (SVP, Technical Operations) | Sale | 110 | 30.00 | 3,300 |
| 2017-12-04 | Simpson Curran (SVP, Technical Operations) | Option Ex | 110 | 13.09 | 1,439 |
| 2017-11-27 | Simpson Curran (SVP, Technical Operations) | Sale | 2,000 | 29.31 | 58,620 |
| 2017-11-27 | Simpson Curran (SVP, Technical Operations) | Option Ex | 2,000 | 13.09 | 26,180 |
| 2017-11-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 27.71 | 277,100 |
| 2017-11-20 | Mills Kenneth T. (President and CEO) | Option Ex | 30,000 | .85 | 25,500 |
| 2017-11-15 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 25.30 | 126,500 |
| 2017-10-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 32.82 | 328,200 |
| 2017-10-16 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 33.25 | 166,250 |
| 2017-10-11 | Hayden Donald J Jr | Sale | 20,000 | 34.95 | 699,000 |
| 2017-10-11 | Hayden Donald J Jr | Option Ex | 20,000 | .85 | 17,000 |
| 2017-09-27 | Hayden Donald J Jr | Sale | 20,000 | 32.45 | 649,000 |
| 2017-09-27 | Hayden Donald J Jr | Option Ex | 20,000 | .85 | 17,000 |
| 2017-09-20 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 29.68 | 296,850 |
| 2017-09-18 | Hayden Donald J Jr | Sale | 20,000 | 29.95 | 599,000 |
| 2017-09-18 | Hayden Donald J Jr | Option Ex | 20,000 | .85 | 17,000 |
| 2017-09-15 | Vasista Vittal (Chief Financial Officer) | Sale | 5,000 | 27.41 | 137,050 |
| 2017-09-15 | Hayden Donald J Jr | Sale | 20,000 | 27.45 | 549,000 |
| 2017-09-15 | Hayden Donald J Jr | Option Ex | 20,000 | .85 | 17,000 |
| 2017-09-08 | Yoo Stephen (Chief Medical Officer) | Sale | 27,342 | 25.00 | 683,550 |
| 2017-09-08 | Yoo Stephen (Chief Medical Officer) | Option Ex | 27,342 | .85 | 23,240 |
| 2017-09-06 | Yoo Stephen (Chief Medical Officer) | Sale | 855 | 25.00 | 21,375 |
| 2017-09-06 | Yoo Stephen (Chief Medical Officer) | Option Ex | 855 | .85 | 726 |
| 2017-09-05 | Yoo Stephen (Chief Medical Officer) | Sale | 31,803 | 25.00 | 795,075 |
| 2017-09-05 | Yoo Stephen (Chief Medical Officer) | Option Ex | 31,803 | .85 | 27,032 |
| 2017-09-05 | Mills Kenneth T. (President and CEO) | Sale | 10,500 | 25.00 | 262,500 |
| 2017-09-05 | Hayden Donald J Jr | Sale | 20,000 | 24.95 | 499,000 |
| 2017-09-05 | Hayden Donald J Jr | Option Ex | 20,000 | .85 | 17,000 |
| 2017-08-25 | Mills Kenneth T. (President and CEO) | Option Ex | 23,530 | .85 | 20,000 |
| 2017-08-21 | Yoo Stephen (Chief Medical Officer) | Sale | 15,000 | 20.03 | 300,450 |
| 2017-08-21 | Yoo Stephen (Chief Medical Officer) | Option Ex | 15,000 | .85 | 12,750 |
| 2017-08-21 | Mills Kenneth T. (President and CEO) | Sale | 6,500 | 20.05 | 130,325 |
| 2017-08-15 | Vasista Vittal (Chief Financial Officer) | Sale | 3,040 | 21.20 | 64,432 |
| 2017-07-20 | Yoo Stephen (Chief Medical Officer) | Sale | 15,000 | 18.66 | 279,900 |
| 2017-07-20 | Yoo Stephen (Chief Medical Officer) | Option Ex | 15,000 | .85 | 12,750 |
| 2017-07-20 | Mills Kenneth T. (President and CEO) | Sale | 6,500 | 18.66 | 121,290 |
| 2017-07-17 | Vasista Vittal (Chief Financial Officer) | Sale | 3,100 | 19.81 | 61,410 |
| 2017-06-20 | Yoo Stephen (Chief Medical Officer) | Sale | 15,000 | 19.88 | 298,125 |
| 2017-06-20 | Yoo Stephen (Chief Medical Officer) | Option Ex | 15,000 | .85 | 12,750 |
| 2017-06-20 | Mills Kenneth T. (President and CEO) | Sale | 6,500 | 19.88 | 129,220 |
| 2017-06-15 | Vasista Vittal (Chief Financial Officer) | Sale | 3,100 | 18.75 | 58,125 |
| 2017-05-15 | Vasista Vittal (Chief Financial Officer) | Sale | 3,100 | 19.07 | 59,117 |
| 2017-05-15 | Hayden Donald J Jr (Director) | Sale | 8,599 | 19.04 | 163,724 |
| 2017-05-08 | Hayden Donald J Jr (Director) | Sale | 10,000 | 18.35 | 183,500 |
| 2017-05-01 | Hayden Donald J Jr (Director) | Sale | 30,000 | 21.89 | 656,550 |
| 2017-05-01 | Hayden Donald J Jr (Director) | Option Ex | 20,000 | .85 | 17,000 |
| 2017-04-24 | Vasista Vittal (Chief Financial Officer) | Sale | 3,100 | 21.18 | 65,673 |
| 2017-04-24 | Mills Kenneth T. (President and CEO) | Sale | 15,440 | 21.17 | 326,864 |
| 2017-04-24 | Hayden Donald J Jr (Director) | Sale | 10,000 | 20.98 | 209,800 |
| 2016-06-13 | Mills Kenneth T. (President and CEO) | Option Ex | 125,000 | .85 | 106,250 |
| 2016-05-17 | Fmr Llc (Other) | Sale | 18,300 | 12.41 | 227,103 |
| 2016-05-16 | Fmr Llc (Other) | Sale | 10,500 | 11.95 | 125,517 |
| 2016-05-13 | Fmr Llc (Other) | Sale | 5,530 | 11.27 | 62,306 |
| 2016-05-12 | Fmr Llc (Other) | Sale | 6,711 | 10.90 | 73,176 |
| 2016-05-11 | Fmr Llc (Other) | Sale | 14,189 | 10.63 | 150,885 |
| 2016-05-10 | Fmr Llc (Other) | Sale | 10,943 | 10.11 | 110,677 |
| 2016-05-09 | Fmr Llc (Other) | Sale | 5,731 | 9.91 | 56,777 |
| 2016-05-06 | Fmr Llc (Other) | Sale | 4,839 | 9.95 | 48,167 |
| 2016-05-04 | Fmr Llc (Other) | Sale | 1,896 | 10.47 | 19,860 |
| 2016-05-03 | Fmr Llc (Other) | Sale | 3,650 | 10.76 | 39,266 |
| 2016-05-02 | Fmr Llc (Other) | Sale | 2,396 | 10.85 | 25,996 |
| 2016-04-28 | Fmr Llc (Other) | Sale | 4,918 | 11.31 | 55,627 |
| 2016-04-27 | Fmr Llc (Other) | Sale | 28,278 | 11.19 | 316,289 |
| 2016-04-26 | Fmr Llc (Other) | Sale | 5,300 | 11.12 | 58,935 |
| 2016-04-25 | Fmr Llc (Other) | Sale | 3,888 | 11.29 | 43,895 |
| 2016-04-22 | Fmr Llc (Other) | Sale | 17,358 | 11.30 | 196,145 |
| 2016-04-21 | Fmr Llc (Other) | Sale | 3,200 | 11.28 | 36,096 |
| 2016-04-20 | Fmr Llc (Other) | Sale | 4,200 | 11.42 | 47,964 |
| 2016-04-19 | Fmr Llc (Other) | Sale | 8,989 | 11.77 | 105,800 |
| 2016-04-18 | Fmr Llc (Other) | Sale | 9,600 | 11.94 | 114,624 |
| 2016-04-15 | Fmr Llc (Other) | Sale | 9,300 | 11.56 | 107,508 |
| 2016-04-14 | Fmr Llc (Other) | Sale | 4,734 | 11.57 | 54,772 |
| 2016-04-13 | Fmr Llc (Other) | Sale | 20,000 | 11.44 | 228,800 |
| 2016-04-12 | Fmr Llc (Other) | Sale | 2,302 | 11.44 | 26,334 |
| 2015-09-22 | Deerfield Partners, Lp | Buy | 175,000 | 22.00 | 3,850,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regenxbio Inc. (symbol RGNX, CIK number 1590877) see the Securities and Exchange Commission (SEC) website.